博雅生物：2025年第三季度归属于上市公司股东的净利润同比增长21.59%

Group 1 - The core viewpoint of the article is that Boya Bio reported significant growth in its financial performance for the third quarter of 2025, indicating a strong business trajectory [1] Group 2 - In the third quarter of 2025, the company achieved operating revenue of 466,151,253.70 yuan, representing a year-on-year increase of 33.43% [1] - The net profit attributable to shareholders of the listed company was 117,620,874.70 yuan, reflecting a year-on-year growth of 21.59% [1]